As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
COVID-19 and impact on peer review
Real Frontier in Clinical Applications of Regeneration Medicine
Guest edited by Kazuo Tsubota
Recent Progress in Osteoimmunology
Guest edited by Hiroshi Takayanagi
Regenerative Medicine and Disease Modeling using iPS cells
Guest edited by Hideyuki Okano
Immunoregulation for Regenerative Medicine
Guest edited by Motokazu Tsujikawa
Inflammation and Aging
Guest edited by Motoko Yanagita
A New Era of Stem Cell Therapy for Disease
Guest edited by Tetsuya Taga
Strategies for regulating tissue fibrosis and their clinical application
Guest edited by Masataka Kuwana
Inflammation and blood vessel formation
Guest edited by Nobuyuki Takakura
Tissue stem cells as a novel therapeutic strategy for inflammatory disease
Guest edited by Takahiro Ochiya
Imaging of inflammation and regeneration
Guest edited by Masaru Ishii
Arthritis and cartilage regeneration
Guest edited by Noriyuki Tsumaki
Biological barrier and inflammatory diseases
Guest edited by Koji Hase
Introduction of microcapillary in 3D engineered tissue
Guest edited by Ikuo Morita
Vascular and neuro-inflammation
Guest edited by Susumu Ishida
Inflammation and regeneration in cross-organs
Guest edited by Seiji Okada
Aging and inflammation
Guest edited by Issei Komuro
New targets and new strategy for the treatment of systemic autoimmune diseases
Guest edited by Yoshiya Tanaka
Chronic inflammation and endogenous ligands
Guest edited by Atsushi Kumanogoh
Inflammation and Regeneration was founded in 1980 and transferred to BioMed Central in 2016. Articles published in the journal between 2006 and 2015 are fully accessible from the following link.
Aims and scope
Inflammation and Regeneration provides an open access forum which covers a wide range of scientific topics in the research field of basic and clinical regenerative medicine. Inflammation research and regenerative medicine are tightly linked research areas in life sciences and their significance in translational research is rapidly increasing. From this aspect, this journal encourages the submission of manuscripts whose scope bridges these fields of research.
Authors publishing in Inflammation and Regeneration can request a discount on the journal’s article-processing charge (APC) that is payable upon editorial acceptance of articles. The discount must be requested during the article submission process, by entering a code that can be obtained from the Japanese Society of Inflammation and Regeneration. The discounted APC is €500 for non-commissioned articles submitted after 1 January 2018. The APCs of commissioned articles are covered by the Society, so authors do not need to pay the APC.
We are pleased to announce that all articles published after 2016 in Inflammation and Regeneration are included in PubMed, PubMed Central and DOAJ.
The 40th Annual Meeting of the Japanese Society of Inflammation and Regeneration
July 16-17, 2019
Hideyuki Okano, Editor-in-Chief
Dr Okano is currently Dean of Keio University School of Medicine, Tokyo, Japan. He also serves as Professor of Department of Physiology at the same school.
Dr Okano has been conducting basic research in the field of restorative medicine including, neural stem cells and iPS cells, spinal cord injury, developmental genetics and RNA binding proteins. He has been awarded numbers of awards and honors including the Medal with Purple Ribbon in 2009. Dr Okano is currently the Vice President of Japanese Society of Neuroscience, and a member of the Board of Directors at the Japanese Society of Inflammation and Regeneration (JSIR) and International Society for Stem Cell Research (ISSCR). Dr Okano has been the Editor-in-Chief of Inflammation and Regeneration since April 2004.
The official journal of the Japanese Society of Inflammation and Regeneration.
Annual Journal Metrics
46 days to first decision for reviewed manuscripts only
42 days to first decision for all manuscripts
100 days from submission to acceptance
29 days from acceptance to publication
19 Altmetric Mentions